BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 28991552)

  • 1. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
    Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
    Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
    J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
    Samuelson Bannow B; Warad DM; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Sharma R; Grill DE; Redman MW; Khalighi PR; Leger RR; Pruthi RK; Chen D; Sabath DE; Aster RH; Garcia DA; Padmanabhan A
    Blood; 2021 Feb; 137(8):1082-1089. PubMed ID: 32898858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
    Raschke RA; Curry SC; Warkentin TE; Gerkin RD
    Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-release assay-negative heparin-induced thrombocytopenia.
    Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
    Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia.
    Arora K; Rodgers S; Alkhatib Y; Onwubiko IN; Padmanabhan A; Otrock ZK
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):522-525. PubMed ID: 34261860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
    Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
    Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
    Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
    J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New platelet functional method for identification of pathogenic antibodies in HIT patients.
    Guarino ML; Massimi I; Mardente S; Lappa A; Donfrancesco S; Visentin GP; Pulcinelli FM
    Platelets; 2017 Nov; 28(7):728-730. PubMed ID: 28287032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
    Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
    Rubino JG; Arnold DM; Warkentin TE; Smith JW; Kelton JG; Nazy I
    J Thromb Haemost; 2021 Apr; 19(4):1096-1102. PubMed ID: 33387395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.
    Arepally G; Reynolds C; Tomaski A; Amiral J; Jawad A; Poncz M; Cines DB
    Am J Clin Pathol; 1995 Dec; 104(6):648-54. PubMed ID: 8526207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.